Document Detail


Putative targeting of matrix metalloproteinase-8 in atherosclerosis.
MedLine Citation:
PMID:  25448039     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
There is compelling evidence indicating that some members of the matrix metalloproteinase (MMP) family play important roles in the pathogenesis of atherosclerosis and related vascular and cardiac conditions such as atherosclerotic plaque rupture leading to myocardial infarction, heart failure after myocardial infarction, neointima formation following angioplasty, and abdominal aortic aneurysm. Studies have shown that administration of MMP inhibitors can deter some of these conditions in experimental animal models, but few pertinent human clinical trials have been reported to date. Clinical studies of broad-spectrum MMP inhibitors in cancers and arthritis, however, have reported considerable side effects that are likely to be related to the lack of selectivity of these inhibitors. Since different members of the MMP family can have divergent and even opposing functions, it is believed that selective MMP inhibitors that specifically target particular MMPs that are key in the disease pathogenesis will likely have greater efficacy and less adverse effects. In recent years there has been accumulating evidence indicating an important role of MMP8 in atherosclerosis and the associated conditions mentioned above. This article will review findings from studies examining MMP8 in relation to these conditions and discuss rationale of targeting MMP8 as a potential therapeutic strategy.
Authors:
Shu Ye
Related Documents :
20403579 - Serum levels of apelin and ghrelin in patients with acute coronary syndromes and establ...
11512689 - Predictive value of mitral annular calcification for the diagnosis of coronary artery d...
1505549 - Stress doppler echocardiography using dobutamine in coronary patients with and without ...
10966129 - Leukocyte counts and concentrations of soluble adhesion molecules as predictors of coro...
20800799 - Distribution of left ventricular ejection fraction and heart rate values in a cohort of...
7588939 - Myocardial technetium-99m sestamibi single-photon emission tomography as a prognostic t...
8717639 - Heart failure from diastolic dysfunction.
3995529 - Computerized echocardiographic study of left ventricular function and cardiodynamic inv...
19318149 - Assessment of fetal cardiac function before and after therapy for twin-to-twin transfus...
Publication Detail:
Type:  REVIEW     Date:  2014-11-14
Journal Detail:
Title:  Pharmacology & therapeutics     Volume:  -     ISSN:  1879-016X     ISO Abbreviation:  Pharmacol. Ther.     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-12-3     Completed Date:  -     Revised Date:  2014-12-3    
Medline Journal Info:
Nlm Unique ID:  7905840     Medline TA:  Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Emerging roles of the ?-secretase-notch axis in inflammation.
Next Document:  Leukocyte integrins: Role in leukocyte recruitment and as therapeutic targets in inflammatory diseas...